Davenport & CO LLC Edwards Lifesciences Corp Transaction History

Davenport & CO LLC

$16.8 Billion
Q3 2024

A detailed history of Davenport & CO LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Davenport & CO LLC holds 3,031 shares of EW stock, worth $216,261. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,031

Holding current value

$216,261

% of portfolio

0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$59.7 - $93.78 $180,950 - $284,247	3,031 New	3,031 $200,000
Q4 2023 Jan 23, 2024	BUY	$61.71 - $77.76 $174,639 - $220,060	2,830 New	2,830 $215,000
Q2 2023 Jul 20, 2023	BUY	$81.41 - $94.33 $3,419 - $3,961	42 Added 1.48%	2,889 $272,000
Q1 2023 Apr 27, 2023	SELL	$74.26 - $84.51 $42,105 - $47,917	-567 Reduced 16.61%	2,847 $235,000
Q4 2022 Jan 20, 2023	SELL	$68.3 - $87.44 $203,943 - $261,095	-2,986 Reduced 46.66%	3,414 $0
Q3 2022 Oct 11, 2022	SELL	$82.37 - $107.29 $48,104 - $62,657	-584 Reduced 8.36%	6,400 $529,000
Q2 2022 Jul 18, 2022	SELL	$86.5 - $128.27 $41,693 - $61,826	-482 Reduced 6.46%	6,984 $664,000
Q1 2022 May 02, 2022	BUY	$101.96 - $128.34 $42,415 - $53,389	416 Added 5.9%	7,466 $879,000
Q4 2021 Feb 10, 2022	BUY	$106.37 - $130.68 $25,528 - $31,363	240 Added 3.52%	7,050 $913,000
Q3 2021 Oct 14, 2021	BUY	$102.91 - $122.75 $45,486 - $54,255	442 Added 6.94%	6,810 $771,000
Q2 2021 Jul 28, 2021	BUY	$83.84 - $104.76 $305,093 - $381,221	3,639 Added 133.35%	6,368 $660,000
Q1 2021 Apr 28, 2021	SELL	$78.68 - $90.67 $31,472 - $36,268	-400 Reduced 12.78%	2,729 $228,000
Q3 2020 Oct 15, 2020	SELL	$67.19 - $87.44 $56,842 - $73,974	-846 Reduced 21.28%	3,129 $250,000
Q2 2020 Jul 28, 2020	BUY	$57.54 - $76.95 $151,042 - $201,993	2,625 Added 194.44%	3,975 $275,000
Q1 2020 May 05, 2020	SELL	$52.41 - $81.0 $8,175 - $12,636	-156 Reduced 10.36%	1,350 $255,000
Q4 2019 Jan 22, 2020	SELL	$71.7 - $82.09 $6,739 - $7,716	-94 Reduced 5.88%	1,506 $351,000
Q1 2019 Apr 17, 2019	SELL	$47.89 - $64.05 $1,436 - $1,921	-30 Reduced 1.84%	1,600 $306,000
Q4 2018 Jan 28, 2019	SELL	$46.41 - $56.94 $4,641 - $5,694	-100 Reduced 5.78%	1,630 $250,000
Q3 2018 Oct 11, 2018	BUY	$45.7 - $58.03 $3,199 - $4,062	70 Added 4.22%	1,730 $301,000
Q2 2018 Jul 09, 2018	BUY	$42.45 - $51.3 $70,467 - $85,158	1,660 New	1,660 $242,000

Others Institutions Holding EW

# of Institutions

1,349

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.47 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.64 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.25 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.87 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$965 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $44.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Account